title: Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
abstract: The incidence of mucormycosis, defined as systemic infection caused by fungi of the class Phycomycetes has been increasing over the past 2 decades, especially in profoundly immunocompromised hosts. We report a new case in a patient presenting with post-transplant high-grade non-Hodgkin's lymphoma who received a prolonged treatment with voriconazole and caspofungin for an invasive pulmonary aspergillosis. Definite diagnosis of mucormycosis was made by liver biopsy of nodules mimicking progressive lymphoma. The patient died 1 week after the diagnosis of mucormycosis despite the administration of liposomal amphotericin B. The role of voriconazole and caspofungin in the emergence of mucormycosis is discussed.
authors.affiliation: Haematology Department, University Hospital Hôtel-Dieu, Place Alexis Ricordeau, Nantes Cedex, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Blin
authors.forename: Nadine
authors.initials: N
authors.lastname: Morineau
authors.forename: Fanny
authors.initials: F
authors.lastname: Gaillard
authors.forename: Odile
authors.initials: O
authors.lastname: Morin
authors.forename: Noël
authors.initials: N
authors.lastname: Milpied
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Harousseau
authors.forename: Philippe
authors.initials: P
authors.lastname: Moreau
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D000077336:Caspofungin; D054714:Echinocandins; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D055666:Lipopeptides; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D009091:Mucormycosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D010456:Peptides, Cyclic / Q000009:adverse effects; D011743:Pyrimidines / Q000009:adverse effects; D017211:Treatment Failure; D014230:Triazoles / Q000009:adverse effects; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D000077336:Caspofungin; D065819:Voriconazole